Format

Send to

Choose Destination
Science. 2014 May 30;344(6187):967-9. doi: 10.1126/science.1251419.

Target small firms for antibiotic innovation.

Author information

1
Faculty of Arts and Sciences, Harvard University, Cambridge, MA 02138, USA. Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. tjhwang@post.harvard.edu akesselheim@partners.org.
2
Faculty of Arts and Sciences, Harvard University, Cambridge, MA 02138, USA. Radcliffe Institute for Advanced Study, Harvard University, Cambridge, MA 02138, USA.
3
Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. tjhwang@post.harvard.edu akesselheim@partners.org.
PMID:
24876477
DOI:
10.1126/science.1251419
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center